1. MARKETS
  2. SECTOR : DIVERSIFIED CONSUMER SERVICES
  3. INDUSTRY : HEALTHCARE SERVICES
  4. TRANSGENE BIOTEK LTD.

Transgene Biotek Ltd.

BSE: 526139

Download real time

3.65 0.00 (0.00%)

66.33% Fall from 52W High

39,129 BSE Volume

BSE 11 Apr, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
13S
10W
0O
0T
27.7

Market Cap

Low in industry
-118

PE TTM

Negative PE TTM
-1.4

PEG TTM

PEG TTM is negative
2.6

Price to Book

Below industry Median
0.4

Beta 1Year

Very Low volatility


Board Meetings - Transgene Biotek Ltd.

The latest board meeting for Transgene Biotek Ltd. took place on 24 Jan 2025, for the purpose of Quarterly Results

Share
Ex-date Purpose Notes
24 Jan 2025 Quarterly Results -
12 Nov 2024 Quarterly Results & A.G.M. -
10 Aug 2024 Quarterly Results -
30 May 2024 Audited Results -
14 Feb 2024 Quarterly Results -
14 Nov 2023 Quarterly Results & Others -
05 Aug 2023 Quarterly Results & Others -
30 May 2023 Audited Results -
14 Feb 2023 Quarterly Results -
12 Nov 2022 Quarterly Results -
13 Aug 2022 Quarterly Results & A.G.M. -
30 May 2022 Audited Results -
14 Feb 2022 Quarterly Results -
12 Nov 2021 Quarterly Results -
14 Aug 2021 Quarterly Results -
29 Jun 2021 Audited Results -
23 Jan 2021 Quarterly Results -
10 Nov 2020 Quarterly Results -
24 Aug 2020 Quarterly Results -
03 Jun 2020 Audited Results -
04 Mar 2020 Others Inter alia, to consider and approve 1) To Discuss and approve the Letter of Resignation submitted by Mr.Vikram Polavarupu as Director of the Board and also, as Managing Director due to health issues.
04 Feb 2020 Quarterly Results -
12 Nov 2019 Quarterly Results & Others -
28 Aug 2019 Others inter alia, to consider and approve 1) To fix the date for convening the 29th Annual General Meeting of the Company.
14 Aug 2019 Quarterly Results -
24 May 2019 Audited Results -
14 Feb 2019 Quarterly Results -
14 Nov 2018 Quarterly Results -
14 Aug 2018 Unaudited Financial Results -
28 May 2018 Audited Results -
20 Mar 2018 Others To discuss about the wrong application of an Accounting Standard with regard to gains in foreign exchange fluctuation for the year ended March 31, 2012.
14 Feb 2018 Quarterly Results -
13 Nov 2017 Quarterly Results -
14 Aug 2017 Quarterly Results -
30 May 2017 Quarterly Results -
15 Mar 2017 Quarterly Results BM date has been revised from 14/02/2017
14 Nov 2016 Quarterly Results -
02 Sep 2016 Others 1. To approve Directors Report for the year ended March 31, 2016. 2. To fix date for convening the 26th Annual General Meeting of the Company.
15 Feb 2016 Quarterly Results -
13 Nov 2015 Quarterly Results -
04 Sep 2015 Others 1. To approve the annual consolidated accounts of the Company. 2. To consider the reappointment of directors and resignation of the existing directors.
14 Aug 2015 Quarterly Results -
30 May 2015 Quarterly Results -
17 Apr 2015 Appointment of Women Director -
12 Feb 2015 Quarterly Results -
03 Dec 2014 Others 1. To approve the annual consolidated accounts of the Company. 2. To fix the date for convening the 24th Annual General Meeting of the Company. 3. To fix the date of book closure
15 Nov 2014 Quarterly Results -
14 Aug 2014 Quarterly Results -
30 May 2014 Audited Results -
11 Feb 2014 Quarterly Results -
15 Nov 2013 Quarterly Results -
07 Oct 2013 Allotment of shares To allot shares to Dr. K. K. Rao, Promoter of the Company against the unsecured loans brought in by Dr. K. K. Rao and family.
15 Aug 2013 Quarterly Results & Others -
30 May 2013 Audited Results -
15 Feb 2013 Quarterly Results -
15 Nov 2012 Quarterly Results -
03 Sep 2012 Others To consider the proposal for delisting the equity Shares of the Company from all the recognized Indian stock exchanges.
15 Aug 2012 Quarterly Results -
30 May 2012 Quarterly Results (Revised)
15 Feb 2012 Quarterly Results -
15 Nov 2011 Quarterly Results -
30 Sep 2011 Others -
05 Sep 2011 Audited Results -
15 Aug 2011 Quarterly Results -
14 May 2011 Quarterly Results -
18 Feb 2011 Others To decide upon the opening of the Issue of GDRs upto USD 40 million.
12 Feb 2011 Quarterly Results -
10 Nov 2010 Quarterly Results -
30 Sep 2010 Increase in Authorised Capital & Others To increase the Authorized Capital of the Company from Rs. 20 Crs to Rs. 75 Crs & to raise funds for the Company either from the International Markets through issue of Securities.
04 Sep 2010 Audited Results To fix the date for covening the Annual General Meeting of the Company & to fix the date of book closure.
31 Jul 2010 Quarterly Results -
27 Apr 2010 Quarterly Results -
30 Jan 2010 Quarterly Results -
31 Oct 2009 Quarterly Results -
05 Sep 2009 Audited Results -
31 Jul 2009 Quarterly Results -
30 Apr 2009 Quarterly Results -
31 Jan 2009 Quarterly Results -
31 Oct 2008 Audited, Quarterly Results & Others To consider allotment of 7,50,000 Equity Shares of Rs 10/- each @ Rs 80/- per equity share on preferential basis to Dr. K K Rao.
30 Apr 2008 Quarterly Results & Others To consider the proposal for conversion of the unsecured loans brought in by Dr. K K Rao and associates, Promoter of the Company, into equity.
31 Jan 2008 Quarterly Results -
31 Oct 2007 Quarterly Results -
03 Sep 2007 Audited Results -
30 Apr 2007 Quarterly Results -
31 Jan 2007 Quarterly Results -
31 Oct 2006 Accounts & Quarterly Results -
31 Jul 2006 Quarterly Results -
29 Apr 2006 Quarterly Results -
23 Jan 2006 Quarterly Results -
25 Nov 2005 Preferential Issue of shares against the amount given as loans to the company by Dr. K K Rao (Deffered)
29 Oct 2005 Quarterly Results -
30 Jul 2005 Quarterly Results -
04 Jul 2005 Accounts -
27 Apr 2005 Quarterly Results & Others To allot shares of the Company to the shareholders of M/S Saket Bio-technologies Pvt. Ltd. as per Scheme of Arrangement.
29 Jan 2005 Quarterly Results -
02 Dec 2004 AGM -
29 Oct 2004 Quarterly Results -
30 Jul 2004 Quarterly Results -
21 Apr 2004 Quarterly Results -
22 Mar 2004 Others To approve draft scheme of Arrangement for Amalgamation of M/s. Saket Bio-technologies Pvt. Ltd. with the company.